Moshe Finel

Publication Activity (10 Years)

Years Active: 2014-2019
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Molecular Docking

Hydrogen Peroxide

Top Venues

Molecular pharmaceutics

Drug metabolism and disposition: the biological fate of chemicals

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Moshe Finel, Erkka Järvinen
Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed? British journal of clinical pharmacology 85 (4) (2019)
Risto Olavi Juvonen, Sanna Rauhamäki, Sami Kortet, Sanna Niinivehmas, Johanna Troberg, Aleksanteri Petsalo, Juhani Huuskonen, Hannu Raunio, Moshe Finel, Olli Taneli Pentikäinen
Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10. Molecular pharmaceutics 15 (3) (2018)
Erkka Järvinen, Johanna Troberg, Heidi Kidron, Moshe Finel
Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport. Molecular pharmaceutics 14 (10) (2017)
Johanna Troberg, Erkka Järvinen, Guang-Bo Ge, Ling Yang, Moshe Finel
UGT1A10 Is a High Activity and Important Extrahepatic Enzyme: Why Has Its Role in Intestinal Glucuronidation Been Frequently Underestimated? Molecular pharmaceutics 14 (9) (2016)
Aleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, Vineetha K Edavana, Stacie M Bratton, Ishwori B Dhakal, Moshe Finel, Susan A Kadlubar, Anna Radominska-Pandya
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives. Drug metabolism and disposition: the biological fate of chemicals 42 (9) (2014)